These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6726006)

  • 1. Dose response of influenza A/Washington/897/80 (H3N2) cold-adapted reassortant virus in adult volunteers.
    Clements ML; Betts RF; Maassab HF; Murphy BR
    J Infect Dis; 1984 May; 149(5):814-5. PubMed ID: 6726006
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers.
    Murphy BR; Clements ML; Madore HP; Steinberg J; O'Donnell S; Betts R; Demico D; Reichman RC; Dolin R; Maassab HF
    J Infect Dis; 1984 May; 149(5):816. PubMed ID: 6726007
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose response of influenza A/Washington/897/80 (H3N2) avian-human reassortant virus in adult volunteers.
    Murphy BR; Clements ML; Tierney EL; Black RE; Stienberg J; Chanock RM
    J Infect Dis; 1985 Jul; 152(1):225-9. PubMed ID: 4008988
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
    Sears SD; Clements ML; Betts RF; Maassab HF; Murphy BR; Snyder MH
    J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children.
    Steinhoff MC; Halsey NA; Wilson MH; Burns BA; Samorodin RK; Fries LF; Murphy BR; Clements ML
    J Infect Dis; 1990 Aug; 162(2):394-401. PubMed ID: 2197335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors.
    Clements ML; Sears SD; Christina K; Murphy BR; Snyder MH
    J Clin Microbiol; 1989 Jan; 27(1):219-22. PubMed ID: 2913033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The selection of cold-adapted variants of the influenza viruses H1N1 and H3N2 and their antigenic and genetic characteristics].
    Podcherniaeva RIa; Döhner L; Medvedeva TE; Aleksandrova GI
    Vopr Virusol; 1991; 36(2):100-2. PubMed ID: 1882517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
    Treanor JJ; Roth FK; Betts RF
    J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.
    Cate TR; Couch RB
    Infect Immun; 1982 Oct; 38(1):141-6. PubMed ID: 7141686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
    Clements ML; O'Donnell S; Levine MM; Chanock RM; Murphy BR
    Infect Immun; 1983 Jun; 40(3):1044-51. PubMed ID: 6852910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.
    Murphy BR; Holley HP; Berquist EJ; Levine MM; Spring SB; Maassab HF; Kendal AP; Chanock RM
    Infect Immun; 1979 Feb; 23(2):253-9. PubMed ID: 422240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.
    Hrabar A; Vodopija I; André FE; Mitchell JR; Maassab HF; Hennessy AV; Davenport FM
    Dev Biol Stand; 1977 Jun 1-3; 39():53-60. PubMed ID: 342317
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60.
    Cox NJ; Maassab HF; Kendal AP
    Virology; 1979 Aug; 97(1):190-4. PubMed ID: 473592
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
    Edwards KM; Snyder P; Thompson JM; Johnson PR; Wright PF
    Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peculiarities of obtaining attenuated thermosensitive recombinants of influenza A virus at the end of the H3N2 epidemic cycle.
    Polezhaev FI; Garmashova LM; Rumovsky VI; Aleksandrova GI; Smorodintsev AA
    Acta Virol; 1980 Jun; 24(4):273-8. PubMed ID: 6106378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers.
    Mortiz AJ; Kunz C; Hofman H; Liehl E; Reeve P; Maassab HF
    J Infect Dis; 1980 Dec; 142(6):857-60. PubMed ID: 7462697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.
    Clements ML; Betts RF; Murphy BR
    Lancet; 1984 Mar; 1(8379):705-8. PubMed ID: 6143042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies in man with cold-recombinant influenza virus (H1N1) live vaccines.
    Reeve P; Gerendas B; Moritz A; Liehl E; Kunz C; Hofmann H; Maassab HF
    J Med Virol; 1980; 6(1):75-83. PubMed ID: 7014783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature-sensitive mutants of influenza A virus: evaluation of the Alaska/77-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers.
    Murphy BR; Chanock RM; Douglas RG; Betts RF; Waterman DH; Holley HP; Hoover DL; Suwanagool S; Nalin DR; Levine MM
    Arch Virol; 1980; 65(2):169-73. PubMed ID: 7425857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.